{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:13:41Z","timestamp":1772892821757,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Becky Babcox Research Fund, University of Michigan","award":["G015617"],"award-info":[{"award-number":["G015617"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS038712"],"award-info":[{"award-number":["R01NS038712"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Regional Development Funds (FEDER) - Competitiveness Factors Operational Programme (COMPETE); Foundation for Science and Technology","award":["POCI-01-0145-FEDER-007038"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007038"]}]},{"name":"Northern Portugal Regional Operational Program","award":["NORTE-01-0145-FEDER-000013"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000013"]}]},{"name":"Foundation for Science and Technology (FCT); Competitiveness Factors Operational Programme","award":["PTDC\/SAU-GMG\/112617\/2009"],"award-info":[{"award-number":["PTDC\/SAU-GMG\/112617\/2009"]}]},{"name":"Foundation for Science and Technology (FCT); Competitiveness Factors Operational Programme","award":["EXPL\/BIM-MEC\/0239\/2012"],"award-info":[{"award-number":["EXPL\/BIM-MEC\/0239\/2012"]}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"crossref","award":["POCI-01-0145-FEDER-016818 (PTDC\/NEU-NMC\/3648\/2014)"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016818 (PTDC\/NEU-NMC\/3648\/2014)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000346","name":"Ataxia UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000346","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Science and Technology (FCT); POPH; QREN; Governo da Rep\u00fablica Portuguesa; EU\/FSE","award":["SFRH\/BD\/78388\/2011"],"award-info":[{"award-number":["SFRH\/BD\/78388\/2011"]}]},{"name":"Foundation for Science and Technology (FCT); POPH; QREN; Governo da Rep\u00fablica Portuguesa; EU\/FSE","award":["SFRH\/BPD\/102317\/2014"],"award-info":[{"award-number":["SFRH\/BPD\/102317\/2014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12035-018-1331-2","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T22:15:49Z","timestamp":1536099349000},"page":"3690-3701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Naila S.","family":"Ashraf","sequence":"first","affiliation":[]},{"given":"Sara","family":"Duarte-Silva","sequence":"additional","affiliation":[]},{"given":"Emily D.","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Maciel","sequence":"additional","affiliation":[]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Teixeira-Castro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-4864","authenticated-orcid":false,"given":"Maria do Carmo","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"2","key":"1331_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","volume":"97","author":"C Costa Mdo","year":"2012","unstructured":"Costa Mdo C, Paulson HL (2012) Toward understanding Machado-Joseph disease. Prog Neurobiol 97(2):239\u2013257. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2011.11.006","journal-title":"Prog Neurobiol"},{"issue":"5","key":"1331_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","volume":"3","author":"L Schols","year":"2004","unstructured":"Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3(5):291\u2013304","journal-title":"Lancet Neurol"},{"issue":"3","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng1194-221","volume":"8","author":"Y Kawaguchi","year":"1994","unstructured":"Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S et al (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8(3):221\u2013228. \n                    https:\/\/doi.org\/10.1038\/ng1194-221","journal-title":"Nat Genet"},{"issue":"3","key":"1331_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000090035","volume":"60","author":"M Lima","year":"2005","unstructured":"Lima M, Costa MC, Montiel R, Ferro A, Santos C, Silva C, Bettencourt C, Sousa A et al (2005) Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal. Hum Hered 60(3):156\u2013163","journal-title":"Hum Hered"},{"issue":"11","key":"1331_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","volume":"58","author":"P Maciel","year":"2001","unstructured":"Maciel P, Costa MC, Ferro A, Rousseau M, Santos CS, Gaspar C, Barros J, Rouleau GA et al (2001) Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 58(11):1821\u20131827","journal-title":"Arch Neurol"},{"issue":"7","key":"1331_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1212\/WNL.28.7.703","volume":"28","author":"P Coutinho","year":"1978","unstructured":"Coutinho P, Andrade C (1978) Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 28(7):703\u2013709","journal-title":"Neurology"},{"issue":"3","key":"1331_CR7","first-page":"203","volume":"29","author":"P Coutinho","year":"1981","unstructured":"Coutinho P, Sequeiros J (1981) Clinical, genetic and pathological aspects of Machado-Joseph disease. J Genet Hum 29(3):203\u2013209","journal-title":"J Genet Hum"},{"issue":"2","key":"1331_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-2007-971172","volume":"27","author":"HL Paulson","year":"2007","unstructured":"Paulson HL (2007) Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3. Semin Neurol 27(2):133\u2013142","journal-title":"Semin Neurol"},{"key":"1331_CR9","first-page":"139","volume":"61","author":"J Sequeiros","year":"1993","unstructured":"Sequeiros J, Coutinho P (1993) Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 61:139\u2013153","journal-title":"Adv Neurol"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","volume":"104","author":"U Rub","year":"2013","unstructured":"Rub U, Schols L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW et al (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 104:38\u201366. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2013.01.001","journal-title":"Prog Neurobiol"},{"issue":"3","key":"1331_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12311-011-0340-8","volume":"11","author":"W Scherzed","year":"2012","unstructured":"Scherzed W, Brunt ER, Heinsen H, de Vos RA, Seidel K, Burk K, Schols L, Auburger G et al (2012) Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). Cerebellum 11(3):749\u2013760. \n                    https:\/\/doi.org\/10.1007\/s12311-011-0340-8","journal-title":"Cerebellum"},{"key":"1331_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-6-35","volume":"6","author":"C Bettencourt","year":"2011","unstructured":"Bettencourt C, Lima M (2011) Machado-Joseph disease: from first descriptions to new perspectives. Orphanet J Rare Dis 6:35. \n                    https:\/\/doi.org\/10.1186\/1750-1172-6-35","journal-title":"Orphanet J Rare Dis"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pneurobio.2015.06.004","volume":"132","author":"X Li","year":"2015","unstructured":"Li X, Liu H, Fischhaber PL, Tang TS (2015) Toward therapeutic targets for SCA3: insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance. Prog Neurobiol 132:34\u201358. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2015.06.004","journal-title":"Prog Neurobiol"},{"issue":"10","key":"1331_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003341","volume":"3","author":"S Alves","year":"2008","unstructured":"Alves S, Nascimento-Ferreira I, Auregan G, Hassig R, Dufour N, Brouillet E, Pedroso de Lima MC, Hantraye P et al (2008) Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. PLoS One 3(10):e3341. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0003341","journal-title":"PLoS One"},{"issue":"12","key":"1331_CR15","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","volume":"19","author":"S Alves","year":"2010","unstructured":"Alves S, Nascimento-Ferreira I, Dufour N, Hassig R, Auregan G, Nobrega C, Brouillet E, Hantraye P et al (2010) Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Hum Mol Genet 19(12):2380\u20132394. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddq111","journal-title":"Hum Mol Genet"},{"issue":"10","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/mt.2013.144","volume":"21","author":"M do Carmo Costa","year":"2013","unstructured":"do Carmo Costa M, Luna-Cancalon K, Fischer S, Ashraf NS, Ouyang M, Dharia RM, Martin-Fishman L, Yang Y et al (2013) Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease. Mol Ther 21(10):1898\u20131908. \n                    https:\/\/doi.org\/10.1038\/mt.2013.144","journal-title":"Mol Ther"},{"issue":"1","key":"1331_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052396","volume":"8","author":"C Nobrega","year":"2013","unstructured":"Nobrega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, Deglon N, de Almeida LP (2013) Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS One 8(1):e52396. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0052396","journal-title":"PLoS One"},{"issue":"10","key":"1331_CR18","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/mt.2013.152","volume":"21","author":"E Rodriguez-Lebron","year":"2013","unstructured":"Rodriguez-Lebron E, Costa MD, Luna-Cancalon K, Peron TM, Fischer S, Boudreau RL, Davidson BL, Paulson HL (2013) Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice. Mol Ther 21(10):1909\u20131918. \n                    https:\/\/doi.org\/10.1038\/mt.2013.152","journal-title":"Mol Ther"},{"key":"1331_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","volume":"7","author":"LR Moore","year":"2017","unstructured":"Moore LR, Rajpal G, Dillingham IT, Qutob M, Blumenstein KG, Gattis D, Hung G, Kordasiewicz HB et al (2017) Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models. Mol Ther Nucleic Acids 7:200\u2013210. \n                    https:\/\/doi.org\/10.1016\/j.omtn.2017.04.005","journal-title":"Mol Ther Nucleic Acids"},{"issue":"November","key":"1331_CR20","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/brain\/aww228","volume":"139","author":"MD Costa","year":"2016","unstructured":"Costa MD, Ashraf NS, Fischer S, Yang Y, Schapka E, Joshi G, McQuade TJ, Dharia RM et al (2016) Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3. Brain 139(November):2891\u20132908. \n                    https:\/\/doi.org\/10.1093\/brain\/aww228","journal-title":"Brain"},{"issue":"Pt 8","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/brain\/aws177","volume":"135","author":"AT Simoes","year":"2012","unstructured":"Simoes AT, Goncalves N, Koeppen A, Deglon N, Kugler S, Duarte CB, Pereira de Almeida L (2012) Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease. Brain 135(Pt 8):2428\u20132439. \n                    https:\/\/doi.org\/10.1093\/brain\/aws177","journal-title":"Brain"},{"issue":"18","key":"1331_CR22","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1093\/hmg\/ddu209","volume":"23","author":"AT Simoes","year":"2014","unstructured":"Simoes AT, Goncalves N, Nobre RJ, Duarte CB, Pereira de Almeida L (2014) Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease. Hum Mol Genet 23(18):4932\u20134944. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu209","journal-title":"Hum Mol Genet"},{"issue":"Pt 1","key":"1331_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/awp292","volume":"133","author":"FM Menzies","year":"2010","unstructured":"Menzies FM, Huebener J, Renna M, Bonin M, Riess O, Rubinsztein DC (2010) Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 133(Pt 1):93\u2013104. \n                    https:\/\/doi.org\/10.1093\/brain\/awp292","journal-title":"Brain"},{"issue":"Pt 7","key":"1331_CR24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1093\/brain\/awt144","volume":"136","author":"I Nascimento-Ferreira","year":"2013","unstructured":"Nascimento-Ferreira I, Nobrega C, Vasconcelos-Ferreira A, Onofre I, Albuquerque D, Aveleira C, Hirai H, Deglon N et al (2013) Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Brain 136(Pt 7):2173\u20132188. \n                    https:\/\/doi.org\/10.1093\/brain\/awt144","journal-title":"Brain"},{"issue":"Pt 5","key":"1331_CR25","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/brain\/awr047","volume":"134","author":"I Nascimento-Ferreira","year":"2011","unstructured":"Nascimento-Ferreira I, Santos-Ferreira T, Sousa-Ferreira L, Auregan G, Onofre I, Alves S, Dufour N, Colomer Gould VF et al (2011) Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. Brain 134(Pt 5):1400\u20131415. \n                    https:\/\/doi.org\/10.1093\/brain\/awr047","journal-title":"Brain"},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"6701793","DOI":"10.1155\/2016\/6701793","volume":"2016","author":"Z Ou","year":"2016","unstructured":"Ou Z, Luo M, Niu X, Chen Y, Xie Y, He W, Song B, Xian Y et al (2016) Autophagy promoted the degradation of mutant ATXN3 in neurally differentiated spinocerebellar ataxia-3 human induced pluripotent stem cells. Biomed Res Int 2016:6701793\u20136701711. \n                    https:\/\/doi.org\/10.1155\/2016\/6701793","journal-title":"Biomed Res Int"},{"key":"1331_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/mds.27292","volume":"33","author":"S Duarte-Silva","year":"2018","unstructured":"Duarte-Silva S, Neves-Carvalho A, Soares-Cunha C, Silva MJ, Teixeira-Castro A, Vieira R, Silva-Fernandes A, Maciel P (2018) Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3. Mov Disord 33:815\u2013826. \n                    https:\/\/doi.org\/10.1002\/mds.27292","journal-title":"Mov Disord"},{"issue":"Pt 11","key":"1331_CR28","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1093\/brain\/awv262","volume":"138","author":"A Teixeira-Castro","year":"2015","unstructured":"Teixeira-Castro A, Jalles A, Esteves S, Kang S, da Silva Santos L, Silva-Fernandes A, Neto MF, Brielmann RM et al (2015) Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain 138(Pt 11):3221\u20133237. \n                    https:\/\/doi.org\/10.1093\/brain\/awv262","journal-title":"Brain"},{"issue":"9","key":"1331_CR29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","volume":"11","author":"CK Cemal","year":"2002","unstructured":"Cemal CK, Carroll CJ, Lawrence L, Lowrie MB, Ruddle P, Al-Mahdawi S, King RH, Pook MA et al (2002) YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet 11(9):1075\u20131094","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1331_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ana.410410408","volume":"41","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Das SS, Crino PB, Perez MK, Patel SC, Gotsdiner D, Fischbeck KH, Pittman RN (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 41(4):453\u2013462. \n                    https:\/\/doi.org\/10.1002\/ana.410410408","journal-title":"Ann Neurol"},{"issue":"1","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rub U (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathol 124(1):1\u201321. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1000-x","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1331_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.cell.2016.08.042","volume":"166","author":"KM Berendzen","year":"2016","unstructured":"Berendzen KM, Durieux J, Shao LW, Tian Y, Kim HE, Wolff S, Liu Y, Dillin A (2016) Neuroendocrine coordination of mitochondrial stress signaling and proteostasis. Cell 166(6):1553\u20131563 e1510. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.08.042","journal-title":"Cell"},{"issue":"2","key":"1331_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cub.2014.11.040","volume":"25","author":"MC Tatum","year":"2015","unstructured":"Tatum MC, Ooi FK, Chikka MR, Chauve L, Martinez-Velazquez LA, Steinbusch HW, Morimoto RI, Prahlad V (2015) Neuronal serotonin release triggers the heat shock response in C. elegans in the absence of temperature increase. Curr Biol 25(2):163\u2013174. \n                    https:\/\/doi.org\/10.1016\/j.cub.2014.11.040","journal-title":"Curr Biol"},{"issue":"7652","key":"1331_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature22078","volume":"545","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC et al (2017) Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545(7652):108\u2013111. \n                    https:\/\/doi.org\/10.1038\/nature22078","journal-title":"Nature"},{"issue":"2","key":"1331_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","volume":"11","author":"A Silva-Fernandes","year":"2014","unstructured":"Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, Amorim M, Soares-Cunha C, Oliveira P, Thirstrup K, Teixeira-Castro A et al (2014) Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurotherapeutics 11(2):433\u2013449. \n                    https:\/\/doi.org\/10.1007\/s13311-013-0255-9","journal-title":"Neurotherapeutics"},{"issue":"31","key":"1331_CR36","doi-asserted-by":"publisher","first-page":"21998","DOI":"10.1074\/jbc.M602302200","volume":"281","author":"PF Teixeira","year":"2006","unstructured":"Teixeira PF, Cerca F, Santos SD, Saraiva MJ (2006) Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem 281(31):21998\u201322003","journal-title":"J Biol Chem"},{"issue":"4","key":"1331_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/70532","volume":"23","author":"JM Warrick","year":"1999","unstructured":"Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, Bonini NM (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23(4):425\u2013428. \n                    https:\/\/doi.org\/10.1038\/70532","journal-title":"Nat Genet"},{"key":"1331_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5638","volume":"5","author":"JR Blount","year":"2014","unstructured":"Blount JR, Tsou WL, Ristic G, Burr AA, Ouyang M, Galante H, Scaglione KM, Todi SV (2014) Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23. Nat Commun 5:4638. \n                    https:\/\/doi.org\/10.1038\/ncomms5638","journal-title":"Nat Commun"},{"issue":"12","key":"1331_CR39","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K, Nukina N (2005) Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem 280(12):11635\u201311640. \n                    https:\/\/doi.org\/10.1074\/jbc.M412042200","journal-title":"J Biol Chem"},{"issue":"3","key":"1331_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.emboj.7600081","volume":"23","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S, Kakizuka A, Kitagawa M et al (2004) Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J 23(3):659\u2013669. \n                    https:\/\/doi.org\/10.1038\/sj.emboj.7600081","journal-title":"EMBO J"},{"issue":"6","key":"1331_CR41","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1471-4159.2007.04460.x","volume":"101","author":"H Wang","year":"2007","unstructured":"Wang H, Jia N, Fei E, Wang Z, Liu C, Zhang T, Fan J, Wu M et al (2007) p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome. J Neurochem 101(6):1651\u20131661. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04460.x","journal-title":"J Neurochem"},{"issue":"1","key":"1331_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","volume":"31","author":"AH Chou","year":"2008","unstructured":"Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL (2008) Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 31(1):89\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2008.03.011","journal-title":"Neurobiol Dis"},{"key":"1331_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/neup.12433","volume":"38","author":"A Sittler","year":"2017","unstructured":"Sittler A, Muriel MP, Marinello M, Brice A, den Dunnen W, Alves S (2017) Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients. Neuropathology 38:113\u2013124. \n                    https:\/\/doi.org\/10.1111\/neup.12433","journal-title":"Neuropathology"},{"issue":"4","key":"1331_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/hmg\/8.4.673","volume":"8","author":"Y Chai","year":"1999","unstructured":"Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3\/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8(4):673\u2013682","journal-title":"Hum Mol Genet"},{"key":"1331_CR45","doi-asserted-by":"publisher","unstructured":"Sofia E, St\u00e9phanie O, Sara DS, Daniela CG, Andreia TC, Patr\u00edcia M (2018) Preclinical evidence supporting early initiation of citalopram treatment in Machado-Joseph disease. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1332-1","DOI":"10.1007\/s12035-018-1332-1"},{"issue":"1","key":"1331_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147515","volume":"11","author":"WT He","year":"2016","unstructured":"He WT, Zheng XM, Zhang YH, Gao YG, Song AX, van der Goot FG, Hu HY (2016) Cytoplasmic ubiquitin-specific protease 19 (USP19) modulates aggregation of polyglutamine-expanded ataxin-3 and huntingtin through the HSP90 chaperone. PLoS One 11(1):e0147515. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147515","journal-title":"PLoS One"},{"issue":"15","key":"1331_CR47","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","volume":"20","author":"A Teixeira-Castro","year":"2011","unstructured":"Teixeira-Castro A, Ailion M, Jalles A, Brignull HR, Vilaca JL, Dias N, Rodrigues P, Oliveira JF et al (2011) Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Hum Mol Genet 20(15):2996\u20133009. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddr203","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1331-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:30:50Z","timestamp":1589895050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1331-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1331-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the University of Michigan Committee on the Use and Care of Animals (Protocol PRO00006371).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}